Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Neurology, Neurosurgery & PsychiatryCalcitonin Gene-Related Peptide in Migraine: Current Therapeutics, Future Implications, and Potential Off-Target Effects

Few classes of therapeutics have been specifically developed to combat migraine, despite its global impact on disability. However, after 30 years of translational research, calcitonin gene-related peptide (CGRP) inhibitors have emerged as a promising new tool in the prevention of migraine.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form